UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
Citi Trends
CTRN
$605M
| $1.13M | ﹤0.01% |
42,861
+40,395
| +1,638% | +$850K |
|
5202
Virtus Investment Partners
VRTS
$1.1B
| $1.12M | ﹤0.01% |
5,088
+1,293
| +34% | +$294K |
|
|
BCV
5203
Bancroft Fund
BCV
$139M
| $1.12M | ﹤0.01% |
63,362
-8,735
| -12% | -$154K |
|
|
MPT
5204
PUT
Medical Properties Trust
MPT
$2.81B
| $1.12M | ﹤0.01% |
283,700
-320,100
| -53% | -$1.43M |
|
5205
Claros Mortgage Trust
CMTG
$274M
| $1.12M | ﹤0.01% |
247,212
+164,931
| +200% | +$1.03M |
|
5206
West Bancorporation
WTBA
$485M
| $1.12M | ﹤0.01% |
51,593
+7,167
| +16% | +$158K |
|
|
GBIO
5207
DELISTED
Generation Bio
GBIO
| $1.12M | ﹤0.01% |
105,351
+20,662
| +24% | +$368K |
|
5208
InfraCap REIT Preferred ETF
PFFR
$121M
| $1.12M | ﹤0.01% |
60,362
+1,102
| +2% | +$21.4K |
|
|
FSCO
5209
FS Credit Opportunities Corp
FSCO
$1.02B
| $1.12M | ﹤0.01% |
163,500
+47,041
| +40% | +$312K |
|
5210
CION Investment
CION
$374M
| $1.11M | ﹤0.01% |
97,502
+8,248
| +9% | +$96.2K |
|
|
GGZ
5211
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$127M
| $1.11M | ﹤0.01% |
94,979
+6,593
| +7% | +$82.4K |
|
5212
VanEck Low Carbon Energy ETF
SMOG
$134M
| $1.11M | ﹤0.01% |
11,216
-2,703
| -19% | -$280K |
|
5213
Blink Charging
BLNK
$87.9M
| $1.11M | ﹤0.01% |
795,791
+463,552
| +140% | +$819K |
|
5214
Energy Recovery
ERII
$443M
| $1.1M | ﹤0.01% |
75,169
+37,394
| +99% | +$640K |
|
|
PMF
5215
DELISTED
PIMCO Municipal Income Fund
PMF
| $1.1M | ﹤0.01% |
122,808
-17,022
| -12% | -$165K |
|
5216
Vanda Pharmaceuticals
VNDA
$302M
| $1.1M | ﹤0.01% |
229,937
+143,056
| +165% | +$687K |
|
5217
Celcuity
CELC
$4.52B
| $1.1M | ﹤0.01% |
83,914
+10,631
| +15% | +$150K |
|
5218
PUT
ResMed
RMD
$30.7B
| $1.1M | ﹤0.01% |
+4,800
| New | +$1.16M |
|
|
NXG
5219
NXG NextGen Infrastructure Income Fund
NXG
$337M
| $1.1M | ﹤0.01% |
23,949
+944
| +4% | +$43.2K |
|
5220
BlackRock MuniHoldings Fund
MHD
$606M
| $1.1M | ﹤0.01% |
93,948
+25,585
| +37% | +$315K |
|
|
IGD
5221
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$517M
| $1.09M | ﹤0.01% |
201,972
+1,847
| +0.9% | +$10.2K |
|
5222
Amerant Bancorp
AMTB
$1.13B
| $1.09M | ﹤0.01% |
48,729
+22,687
| +87% | +$516K |
|
5223
Strategic Education
STRA
$1.92B
| $1.09M | ﹤0.01% |
11,681
-2,888
| -20% | -$270K |
|
5224
iRadimed
IRMD
$1.18B
| $1.09M | ﹤0.01% |
19,800
+13,812
| +231% | +$727K |
|
5225
VanEck Steel ETF
SLX
$176M
| $1.09M | ﹤0.01% |
18,610
-3,520
| -16% | -$238K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.